teaser
Shire plc, theglobal specialty biopharmaceutical company, is committed to doingeverything possible to assist Gaucher patients and their physiciansduring the imiglucerase supply shortage. Shire is pleased to be able toprovide velaglucerase alfa well over a year ahead of previouslyanticipated commercial launch world wide.
Published on 8 September 2009
Update on velaglucerase alfa
Most read
1
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
